Breakthrough cancer treatment prevented leukemia for 10 years, study shows

Undated handout photo issued by Queen’s University Belfast of research in the university’s Centre for Cancer Research & Cell Biology (Queen’s University Belfast/PA)

A breakthrough cancer treatment can prevent the recurrence of leukemia for at least 10 years, a new study shows.

The paper, published in the journal Nature, showed that two patients who were followed for a decade after beginning a trial of Chimeric Antigen Receptor (CAR) T-cell therapy in 2010 have been in remission since starting.